Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary
Human herpesvirus-8 (HHV-8) infection of 130 Hungarian HIV-positive individuals with or without Kaposi's sarcoma was investigated from 158 serum and 122 peripheral blood samples using anti-latency-associated nuclear antigen (LANA) indirect immunofluorescence assay (IFA), recombinant orf65 and orfK8.1 antigen enzyme-linked immunosorbent assays (ELISAs), Western blot assays and orf26 specific nested polymerase chain reaction (PCR). The overall prevalence of HHV-8 infection was found to be 31.5% (41/130) among the Hungarian HIV-positive patients. This seroprevalence rate is 7-11-fold higher than that of healthy HIV-negative blood donors in Hungary. The highest prevalence of HHV-8 infection (36.1%, 35/97) was observed in homo- or bisexual patients. Similar to the serologic results, HHV-8 DNA was not always detectable in all serial samples previously shown to be positive for HHV-8 DNA.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2005 |
---|---|
Erschienen: |
2005 |
Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
---|---|
Enthalten in: |
FEMS immunology and medical microbiology - 43(2005), 2 vom: 01. Feb., Seite 265-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Szalai, Erika [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 04.08.2005 Date Revised 15.11.2006 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM153399449 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM153399449 | ||
003 | DE-627 | ||
005 | 20231223063931.0 | ||
007 | tu | ||
008 | 231223s2005 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0511.xml |
035 | |a (DE-627)NLM153399449 | ||
035 | |a (NLM)15681157 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Szalai, Erika |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary |
264 | 1 | |c 2005 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 04.08.2005 | ||
500 | |a Date Revised 15.11.2006 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Human herpesvirus-8 (HHV-8) infection of 130 Hungarian HIV-positive individuals with or without Kaposi's sarcoma was investigated from 158 serum and 122 peripheral blood samples using anti-latency-associated nuclear antigen (LANA) indirect immunofluorescence assay (IFA), recombinant orf65 and orfK8.1 antigen enzyme-linked immunosorbent assays (ELISAs), Western blot assays and orf26 specific nested polymerase chain reaction (PCR). The overall prevalence of HHV-8 infection was found to be 31.5% (41/130) among the Hungarian HIV-positive patients. This seroprevalence rate is 7-11-fold higher than that of healthy HIV-negative blood donors in Hungary. The highest prevalence of HHV-8 infection (36.1%, 35/97) was observed in homo- or bisexual patients. Similar to the serologic results, HHV-8 DNA was not always detectable in all serial samples previously shown to be positive for HHV-8 DNA | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a Antigens, Viral |2 NLM | |
650 | 7 | |a Nuclear Proteins |2 NLM | |
650 | 7 | |a ORF65 protein, human herpesvirus 8 |2 NLM | |
650 | 7 | |a Recombinant Proteins |2 NLM | |
650 | 7 | |a Viral Proteins |2 NLM | |
650 | 7 | |a latency-associated nuclear antigen |2 NLM | |
700 | 1 | |a Gerlei, Zsuzsanna |e verfasserin |4 aut | |
700 | 1 | |a Szlávik, János |e verfasserin |4 aut | |
700 | 1 | |a Szládek, Györgyi |e verfasserin |4 aut | |
700 | 1 | |a Patel, Ravi |e verfasserin |4 aut | |
700 | 1 | |a Hunyadi, János |e verfasserin |4 aut | |
700 | 1 | |a Gergely, Lajos |e verfasserin |4 aut | |
700 | 1 | |a Juhász, Attila |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t FEMS immunology and medical microbiology |d 1995 |g 43(2005), 2 vom: 01. Feb., Seite 265-8 |w (DE-627)NLM074824104 |x 0928-8244 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2005 |g number:2 |g day:01 |g month:02 |g pages:265-8 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 43 |j 2005 |e 2 |b 01 |c 02 |h 265-8 |